CoChat
Cited by 237

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19

Open access
the STOP-COVID Investigators, Shaefi, Shahzad, Brenner, Samantha K., Gupta, Shruti, O’Gara, Brian P., Krajewski, Megan L., Charytan, David M., Chaudhry, Sobaata, Mirza, Sara H., Peev, Vasil, Anderson, Mark, Bansal, Anip, Hayek, Salim S., Srivastava, Anand, Mathews, Kusum S., Johns, Tanya S., Leonberg-Yoo, Amanda, Green, Adam, Arunthamakun, Justin, Wille, Keith M., Shaukat, Tanveer, Singh, Harkarandeep, Admon, Andrew J., Semler, Matthew W., Hernán, Miguel A., Mueller, Ariel L., Wang, Wei, Leaf, David E. · 2021 · Intensive Care Medicine

Abstract

Limited data are available on venovenous extracorporeal membrane oxygenation (ECMO) in patients with severe hypoxemic respiratory failure from coronavirus disease 2019 (COVID-19). We examined the clinical features and outcomes of 190 patients treated with ECMO within 14 days of ICU admission, using data from a multicenter cohort study of 5122 critically ill adults with COVID-19 admitted to 68 hospitals across the United States. To estimate the effect of ECMO on mortality, we emulated a target trial of ECMO receipt versus no ECMO receipt within 7 days of ICU admission among mechanically ventilated patients with severe hypoxemia (PaO2/FiO2 < 100). Patients were followed until hospital discharge, death, or a minimum of 60 days. We adjusted for confounding using a multivariable Cox model. Among the 190 patients treated with ECMO, the median age was 49 years (IQR 41–58), 137 (72.1%) were men, and the median PaO2/FiO2 prior to ECMO initiation was 72 (IQR 61–90). At 60 days, 63 patients (33.2%) had died, 94 (49.5%) were discharged, and 33 (17.4%) remained hospitalized. Among the 1297 patients eligible for the target trial emulation, 45 of the 130 (34.6%) who received ECMO died, and 553 of the 1167 (47.4%) who did not receive ECMO died. In the primary analysis, patients who received ECMO had lower mortality than those who did not (HR 0.55; 95% CI 0.41–0.74). Results were similar in a secondary analysis limited to patients with PaO2/FiO2 < 80 (HR 0.55; 95% CI 0.40–0.77). In select patients with severe respiratory failure from COVID-19, ECMO may reduce mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00134-020-06331-9

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 237

Metadata

Authors
the STOP-COVID Investigators, Shaefi, S., Brenner, S. K., Gupta, S., O’Gara, B. P., Krajewski, M. L., Charytan, D. M., Chaudhry, S., Mirza, S. H., Peev, V., Anderson, M., Bansal, A., Hayek, S. S., Srivastava, A., Mathews, K. S., Johns, T. S., Leonberg-Yoo, A., Green, A., Arunthamakun, J., Wille, K. M., Shaukat, T., Singh, H., Admon, A. J., Semler, M. W., Hernán, M. A., Mueller, A. L., Wang, W., & Leaf, D. E.
Venue
Intensive Care Medicine
Published
2021-02
Volume
47
Issue
2
Pages
208-221
ISSN
  • 0342-4642 (ISSN-L)
  • 1432-1238
OpenAlex
W3127129273
Cited by
237
References
6
FWCI
14.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.